1-228106801-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_181463.3(MRPL55):​c.346G>T​(p.Val116Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

MRPL55
NM_181463.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -3.75
Variant links:
Genes affected
MRPL55 (HGNC:16686): (mitochondrial ribosomal protein L55) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Multiple transcript variants encoding two different isoforms were identified through sequence analysis. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06493223).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MRPL55NM_181463.3 linkc.346G>T p.Val116Leu missense_variant Exon 5 of 5 ENST00000336520.8 NP_852128.1 Q7Z7F7-1A0A024R3U3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MRPL55ENST00000336520.8 linkc.346G>T p.Val116Leu missense_variant Exon 5 of 5 2 NM_181463.3 ENSP00000337342.3 Q7Z7F7-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 26, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.454G>T (p.V152L) alteration is located in exon 6 (coding exon 4) of the MRPL55 gene. This alteration results from a G to T substitution at nucleotide position 454, causing the valine (V) at amino acid position 152 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
0.021
DANN
Benign
0.76
DEOGEN2
Benign
0.021
T;T;T;T;T;T;.;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.33
.;T;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T
M_CAP
Benign
0.0057
T
MetaRNN
Benign
0.065
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.0
.;.;L;L;L;L;.;L;L;L;L;L;L;L;L;.;L;L;L;L;.
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.1
.;.;N;N;N;N;N;N;N;N;N;N;N;N;N;.;N;N;N;N;N
REVEL
Benign
0.018
Sift
Benign
0.40
.;.;T;T;T;T;T;T;T;T;T;T;T;T;T;.;T;T;T;T;T
Sift4G
Benign
0.20
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.026, 0.055
.;.;B;B;B;B;B;B;B;B;B;B;B;B;B;.;B;B;B;B;B
Vest4
0.16
MutPred
0.54
.;.;Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);.;Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);.;Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);Loss of MoRF binding (P = 0.1057);.;
MVP
0.040
MPC
0.30
ClinPred
0.050
T
GERP RS
-3.0
Varity_R
0.024
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-228294502; API